Qinghai Spring Medicinal Resources Technology Co Ltd Cash Flow Reinvestment Rate
Qinghai Spring Medicinal Resources Technology Co Ltd cash flow reinvestment rate. Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a Cash Flow Reinvestment Rate of 0.10x as of June 2025, reinvesting CN¥1.70 Million (capex CN¥852.18K plus investments CN¥-852.18K) from operating cash flow of CN¥17.29 Million. Explore 600381 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Qinghai Spring Medicinal Resources Technology Co Ltd (1999–2024)
Cash flow reinvestment rate of Qinghai Spring Medicinal Resources Technology Co Ltd from 1999 to 2024. Historical reinvestment intensity for Qinghai Spring Medicinal Resources Technology Co Ltd across 17 annual periods. Explore Qinghai Spring Medicinal Resources Techn capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Qinghai Spring Medicinal Resources Technology Co Ltd Cash Flow Reinvestment Rate by Year (1999–2024)
Qinghai Spring Medicinal Resources Technology Co Ltd cash flow reinvestment rate by year from 1999 to 2024. Year-by-year capital reinvestment analysis for Qinghai Spring Medicinal Resources Technology Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Qinghai Spring Medicinal Resources Techn.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.06x | CN¥5.12 Million | CN¥80.97 Million | CN¥4.93 Million | ▼ -90.0% |
| 2023 | 0.63x | CN¥15.18 Million | CN¥23.92 Million | CN¥13.53 Million | ▼ -89.8% |
| 2017 | 6.21x | CN¥594.72 Million | CN¥95.74 Million | CN¥20.73 Million | ▲ +2035.5% |
| 2016 | 0.29x | CN¥100.36 Million | CN¥344.99 Million | CN¥25.42 Million | ▼ -71.0% |
| 2015 | 1.00x | CN¥835.25 Million | CN¥832.17 Million | CN¥15.25 Million | ▲ +17.6% |
| 2011 | 0.85x | CN¥213.41 Million | CN¥249.98 Million | CN¥213.41 Million | ▼ -83.7% |
| 2010 | 5.24x | CN¥374.71 Million | CN¥71.47 Million | CN¥374.71 Million | ▲ +574.5% |
| 2009 | 0.78x | CN¥30.44 Million | CN¥39.16 Million | CN¥30.44 Million | ▲ +17.8% |
| 2008 | 0.66x | CN¥13.74 Million | CN¥20.83 Million | CN¥13.74 Million | ▲ +29673.3% |
| 2007 | 0.00x | CN¥15.50K | CN¥7.00 Million | CN¥15.50K | — |
| 2006 | 0.00x | CN¥0.00 | CN¥21.57 Million | CN¥0.00 | ▼ -100.0% |
| 2005 | 0.01x | CN¥835.98K | CN¥162.12 Million | CN¥835.98K | ▼ -98.6% |
| 2004 | 0.38x | CN¥12.85 Million | CN¥33.83 Million | CN¥12.85 Million | ▼ -99.5% |
| 2003 | 73.96x | CN¥105.49 Million | CN¥1.43 Million | CN¥105.49 Million | ▲ +1518.0% |
| 2002 | 4.57x | CN¥71.03 Million | CN¥15.54 Million | CN¥71.03 Million | ▼ -51.0% |
| 2000 | 9.32x | CN¥42.13 Million | CN¥4.52 Million | CN¥42.13 Million | ▲ +1161.6% |
| 1999 | 0.74x | CN¥51.93 Million | CN¥70.28 Million | CN¥51.93 Million | — |